A public health genetic approach for schizophrenia

Epidemiologia e Psichiatria Sociale

Volumn 15, Issue 3, 2006, Pages 185-193

  Danese, Andrea ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b De Crespigny Park   (United Kingdom)

Author keywords

Epidemiology; Genetics; Mental health genetics; Schizophrenia

Indexed keywords

CLINICAL TRIAL; EMOTION; ENVIRONMENTAL EXPOSURE; GENE IDENTIFICATION; GENETIC RISK; GENOTYPE; HEREDITY; HUMAN; LINKAGE ANALYSIS; MIGRATION; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PUBLIC HEALTH; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; URBAN AREA;

EID: 33751218578     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1121189X00004437     Document Type: Review

References (95)

1. Abdolmaleky H.M., Smith C.L., Faraone S.V., Shafa R., Stone W., Glatt S.J. & Tsuang M.T. (2004). Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. American Journal of Medical Genetetics 127B, 51-59.
2. Andreasen N.C. (1999). Understanding the causes of schizophrenia. New England Journal of Medicine 340, 645-647.
3. Arseneault L., Cannon M., Witton J. & Murray R.M. (2004). Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 184, 110-117.
4. Badner J.A. & Gershon E.S. (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry 7, 405-411.
5. Bell J. (2004). Predicting disease using genomics. Nature 429, 453-456.
6. Bell R.Q. (1968). A reinterpretation of the direction of effects in studies of socialization. Psychological Review 75, 81-95.
7. Bennedsen B.E., Mortensen P.B., Olesen A.V. & Henriksen T.B. (2001). Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Archives of General Psychiatry 58, 674-679.
8. Burke W. (2003). Genomics as a probe for disease biology. New England Journal of Medicine 349, 969-974.
9. Butzlaff R.L. & Hooley J.M. (1998). Expressed emotion and psychiatric relapse: a meta-analysis. Archives of General Psychiatry 55, 547-552.
10. Cannon M., Jones P.B. & Murray R.M. (2002). Obstetric complications and schizophrenia: historical and meta-analytic review. American Journal of Psychiatry 159, 1080-1092.
11. Cannon T.D. (1996). Abnormalities of brain structure and function in schizophrenia: implications for aetiology and pathophysiology. Annals of Medicine 28, 533-539.
12. Cantor-Graae E. & Selten J.P. (2005). Schizophrenia and migration: a meta-analysis and review. American Journal of Psychiatry 162, 12-24.
13. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A. & Poulton R. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
14. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R. & Craig I.W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57, 1117-1127.
15. Champagne F.A. & Curley J.P. (2005). How social experiences influence the brain. Current Opinion in Neurobiology 15, 704-709.
16. Clayton D. & McKeigue P.M. (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358, 1356-1360.
17. Clayton E.W. (2003). Ethical, legal, and social implications of genomic medicine. New England Journal of Medicine 349, 562-569.
18. Cooper B. (2005). Schizophrenia, social class and immigrant status: the epidemiological evidence. Epidemiologia e Psichiatria Sociale 14, 137-144.
19. Cotter D. & Pariante C.M. (2002). Stress and the progression of the developmental hypothesis of schizophrenia. British Journal of Psychiatry 181, 363-365.
20. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., Braley G., Gueorguieva R. & Krystal J.H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29, 1558-1572.
21. Dawkins R. (1982). The Extended Phenotype: the Gene as Unit of Selection. Oxford University Press: Oxford.
22. Dawkins R. (1989). The Selfish Gene. Oxford University Press: Oxford.
23. Di Forti, M. & Murray, R.M. (2005). Cannabis consumption and risk of developing schizophrenia: myth or reality? Epidemiologia e Psichiatria Sociale 14, 184-187.
24. Dohrenwend B.P. & Dohrenwend B. S. (1969). Social Status and Psychological Disorders: a Causal Inquiry. John Wiley & Sons: New York.
25. Dohrenwend B.P., Levav I., Shrout P.E., Schwartz S., Naveh G., Link B.G., Skodol A.E. & Stueve A. (1992). Socioeconomic status and psychiatric disorders: the causation-selection issue. Science 255, 946-952.
26. Eaton W.W., Day R. & Kramer M. (1988). The use of epidemiology for risk factor research in schizophrenia: an overview and methodological critique. In Handbook of Schizophrenia, vol. 3: Nosology, Epidemiology and Genetics of Schizophrenia (ed. M. Tsuang and J. C. Simpson), pp. 169-204. Elsevier: New York.
27. Garrod A. (1902). The incidence of alkaptonuria: a study in chemical individuality. Lancet 2, 1616-1620.
28. Goldman N. (1994). Social factors and health: the causation-selection issue revisited. Proceedings of the National Academy of Sciences of the United States of America 91, 1251-1255.
29. Goldstein M.J. (1994). Psychoeducational and family therapy in relapse prevention. Acta Psychiatrica Scandinavica, Supplementum No. 382, 54-57.
30. Gottesman I.I. (1991). Schizophrenia Genesis: the Origin of Madness. Freeman: New York.
31. Harrison P.J. & Weinberger D.R. (2005). Schizophrenia genes, gene expression, and neuropathology : on the matter of their convergence. Molecular Psychiatry 10, 40-68; image 45.
32. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U. & van Os J. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 11.
33. Hunter D. J. (2005). Gene-environment interactions in human diseases. Nature Reviews. Genetics 6, 287-298.
34. Jablensky A. (2005). The long and winding road of schizophrenia research. Epidemiologia e Psichiatria Sociale 14, 179-183.
35. Kapur S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 160, 13-23.
36. Kato T., Iwamoto K., Kakiuchi C., Kuratomi G. & Okazaki Y. (2005). Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Molecular Psychiatry 10, 622-630.
37. Kendler K.S. (1997). Social support: a genetic-epidemiologic analysis. American Journal of Psychiatry 154, 1398-1404.
38. Kendler K.S. (2005). "A gene for...": the nature of gene action in psychiatric disorders. American Journal of Psychiatry 162, 1243-1252.
39. Kennedy J.L., Farrer L.A., Andreasen N.C., Mayeux R. & St George-Hyslop P. (2003). The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302, 822-826.
40. Khoury M.J. (2000). Will genetics revolutionize medicine? New England Journal of Medicine 343, 1497.
41. Khoury M.J., Burke W. & Thompson E.J. (2000). Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press: New York.
42. Khoury M.J., Davis R., Gwinn M., Lindegren M.L. & Yoon P. (2005). Do we need genomic research for the prevention of common diseases with environmental causes? American Journal of Epidemiology 161, 799-805.
43. Krabbendam L. & van Os J. (2005). Schizophrenia and urbanicity: a major environmental influence-conditional on genetic risk. Schizophrenia Bulletin 31, 795-799.
44. Kraemer H.C., Kazdin A.E., Offord D.R., Kessler R.C., Jensen P.S. & Kupfer D.J. (1997). Coming to terms with the terms of risk. Archives of General Psychiatry 54, 337-343.
45. Kunugi H., Nanko S., Takei N., Saito K., Murray R.M. & Hirose T. (1996). Perinatal complications and schizophrenia. Data from the Maternal and Child Health Handbook in Japan. Journal of Nervous and Mental Disease 184, 542-546.
46. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lonnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoega T. & Helgason T. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. American Journal of Human Genetetics 73, 34-48.
47. McGrath J. (2002). Prevention of schizophrenia - not an impossible dream. In The Epidemiology of Schizophrenia (ed. R. Murray, P. Jones, E. Susser, J. van Os and M. Cannon), pp. 427-439. Cambridge University Press: Cambridge.
48. McGrath J., Saha S., Welham J., El Saadi O., MacCauley C. & Chant D. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2, 13.
49. McGuffin P. (2004). Nature and nurture interplay: schizophrenia. Psychiatrische Praxis 31, Suppl. 2, S189-193.
50. McGuffin P., Asherson P., Owen M. & Farmer A. (1994). The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? British Journal of Psychiatry 164, 593-599.
51. McGuffin P., Owen M. & Gottesman I. (2002). Psychiatic Genetics and Genomics. Oxford University Press: Oxford.
52. Moffitt T.E., Caspi A. & Rutter M. (2005). Strategy for investigating interactions between measured genes and measured environments. Archives of General Psychiatry 62, 473-481.
53. Mortensen P.B., Pedersen C. B., Westergaard T., Wohlfahrt J., Ewald H., Mors O., Andersen P.K. & Melbye M. (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 340, 603-608.
54. Murray C.L.J. & Lopez A.D. (1996). The Global Burden of Disease. Harvard University Press: Cambridge, MA.
55. Murray R.M. & Lewis S.W. (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal (Clinical Research Edition) 295, 681-682.
56. Murray R., Jones P., Susser E., van Os J. & Cannon M. (2002). The Epidemiology of Schizophrenia. Cambridge University Press: Cambridge.
57. Myin-Germeys I., van Os J., Schwartz J.E., Stone A.A. & Delespaul P.A. (2001). Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 58, 1137-1144.
58. Nimgaonkar V.L., Wessely S. & Murray R.M. (1988). Prevalence of familiality, obstetric complications, and structural brain damage in schizophrenic patients. British Journal of Psychiatry 153, 191-197.
59. O'Callaghan E., Gibson T., Colohan H.A., Buckley P., Walshe D.G., Larkin C. & Waddington J.L. (1992). Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. British Medical Journal 305, 1256-1259.
60. Owen M.J., Craddock N. & O'Donovan M.C. (2005). Schizophrenia: genes at last? Trends in Genetics 21, 518-525.
61. Pariante C.M., Dazzan P., Danese A., Morgan K.D., Brudaglio F., Morgan C., Fearon P., Orr K., Hutchinson G., Pantelis C., Velakoulis D., Jones P.B., Leff J. & Murray R.M. (2005). Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30, 1923-1931.
62. Pedersen C.B. & Mortensen P.B. (2001). Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Archives of General Psychiatry 58, 1039-1046.
63. Pharoah F.M., Rathbone J., Mari J.J. & Streiner D. (2003). Family intervention for schizophrenia. Cochrane Database of Systematic Reviews, Issue 3.
64. Plomin R., DeFries J.C. & Loehlin J.C. (1977). Genotype-environment interaction and correlation in the analysis of human behavior. Psychological Bulletin 84, 309-322.
65. Plomin R., DeFries J.C., McClearn G.E. & McGuffin P. (2001). Behavioral Genetics. Worth Publishers: New York.
66. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L. & Goodwin F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association 264, 2511-2518.
67. Reich D.E., Cargill M., Bolk S., Ireland J., Sabeti P.C., Richter D.J., Lavery T., Kouyoumjian R., Farhadian S.F., Ward R. & Lander E.S. (2001). Linkage disequilibrium in the human genome. Nature 411, 199-204.
68. Risch N.J. (2000). Searching for genetic determinants in the new millennium. Nature 405, 847-856.
69. Rosanoff A.J., Handy L.M., Plesset I.R. & Brush S. (1934). The etiology of so-called schizophrenic psychoses: with special reference to their occurrence in twins. American Journal of Psychiatry 91, 247-286.
70. Rose G. (1994). The Strategy of Preventive Medicine. Oxford University Press: Oxford.
71. Roses A.D. (2000). Pharmacogenetics and the practice of medicine. Nature 405, 857-865.
72. Rutter M. & Silberg J. (2002). Gene-environment interplay in relation to emotional and behavioral disturbance. Annual Review of Psychology 53, 463-490.
73. Rutter M., Pickles A., Murray R. & Eaves L. (2001). Testing hypotheses on specific environmental causal effects on behavior. Psychological Bulletin 127, 291-324.
74. Sacker A., Done D.J. & Crow T.J. (1996). Obstetric complications in children born to parents with schizophrenia: a meta-analysis of case-control studies. Psychological Medicine 26, 279-287.
75. Sankar, P., Cho, M. K., Condit, C. M., Hunt, L. M., Koenig, B., Marshall, P., Lee, S. S. & Spicer, P. (2004). Genetic research and health disparities. Journal of American Medical Association 291, 2985-2989.
76. Scarr S. & McCartney K. (1983). How people make their own environments: a theory of genotype greater than environment effects. Child Development 54, 424-435.
77. Schiffman J., Nakamura B., Earleywine M. & LaBrie J. (2005). Symptoms of schizotypy precede cannabis use. Psychiatry Research 134, 37-42.
78. Selten J.P., Cantor-Graae E., Slaets J. & Kahn R.S. (2002). Odegaard's selection hypothesis revisited: schizophrenia in Surinamese immigrants to The Netherlands. American Journal of Psychiatry 159, 669-671.
79. Sullivan P.F., Kendler K.S. & Neale M.C. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60, 1187-1192.
80. Tabor H.K., Risch N.J. & Myers R.M. (2002). Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nature Reviews. Genetics 3, 391-397.
81. Taubes G. (1995). Epidemiology faces its limits. Science 269, 164-169.
82. Thompson W.D. (1991). Effect modification and the limits of biological inference from epidemiologic data. Journal of Clinical Epidemiology 44, 221-232.
83. Thornicroft G. & Tansella M. (1999). The Mental Health Matrix: a Manual to Improve Services. Cambridge University Press: Cambridge.
84. Tienari P., Wynne L.C., Moring J., Lahti I., Naarala M., Sorri A., Wahlberg K.E., Saarento O., Seitamaa M., Kaleva M. & et al. (1994). The Finnish adoptive family study of schizophrenia. Implications for family research. British Journal of Psychiatry, Suppl. 23, 27-28.
85. Tsuang M. (2000). Schizophrenia: genes and environment. Biological Psychiatry 47, 210-220.
86. van Os J. (2004). Does the urban environment cause psychosis? British Journal of Psychiatry 184, 287-288.
87. van Os J. & Sham P. (2002). Gene-environment correlation and interaction in schizophrenia. In The Epidemiology of Schizophrenia (ed. R. Murray, P. Jones, E. Susser, J. van Os and M. Cannon), pp. 235-253. Cambridge University Press: Cambridge.
88. van Os J., Fahy T.A., Bebbington P., Jones P., Wilkins S., Sham P., Russell A., Gilvarry K., Lewis S., Toone B. & et al. (1994). The influence of life events on the subsequent course of psychotic illness. A prospective follow-up of the Camberwell Collaborative Psychosis Study. Psychological Medicine 24, 503-513.
89. van Os J., Bak M., Hanssen M., Bijl R.V., de Graaf R. & Verdoux H. (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319-327.
90. van Os J., Hanssen M., Bak M., Bijl R.V. & Vollebergh W. (2003). Do urbanicity and familial liability coparticipate in causing psychosis? American Journal of Psychiatry 160, 477-482.
91. Vaughn C. & Leff J. (1976). The measurement of expressed emotion in the families of psychiatric patients. British Journal of Social and Clinical Psychology 15, 157-165.
92. Verdoux H., Gindre C., Sorbara F., Tournier M. & Swendsen J. D. (2003). Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 33, 23-32.
93. Wahlberg K.E., Wynne L.C., Oja H., Keskitalo P., Pykalainen L., Lahti I., Moring J., Naarala M., Sorri A., Seitamaa M., Laksy K., Kolassa J. & Tienari P. (1997). Gene-environment interaction in vulnerability to schizophrenia: findings from the Finnish Adoptive Family Study of Schizophrenia. American Journal of Psychiatry 154, 355-362.
94. Willett W.C. (2002). Balancing life-style and genomics research for disease prevention. Science 296, 695-698.
95. Woo S.M., Goldstein M.J. & Nuechterlein K.H. (1997). Relatives' expressed emotion and non-verbal signs of subclinical psychopathology in schizophrenic patients. British Journal of Psychiatry 170, 58-61.